Anne-Marie Maddox

Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors:…

Journal of Clinical Oncology · 2002 · 485 citations

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations

Archives of Otolaryngology - Head and Neck Surgery · 2004 · 61 citations